0000899243-22-010698.txt : 20220311 0000899243-22-010698.hdr.sgml : 20220311 20220311160819 ACCESSION NUMBER: 0000899243-22-010698 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220309 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIINBERG ULF CENTRAL INDEX KEY: 0001187314 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40908 FILM NUMBER: 22733212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MiNK Therapeutics, Inc. CENTRAL INDEX KEY: 0001840229 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-994-8250 MAIL ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: AgenTus Therapeutics, Inc. DATE OF NAME CHANGE: 20210112 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-09 0 0001840229 MiNK Therapeutics, Inc. INKT 0001187314 WIINBERG ULF 149 FIFTH AVENUE, SUITE 500 NEW YORK NY 10010 1 0 0 0 Stock Option (Right to Buy) 2.89 2022-03-09 4 A 0 15000 0.00 A 2032-03-09 Common Stock 15000 15000 D The option vests in full on the one-year anniversary of the date of grant, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date. By: /s/ Christine Klaskin, Attorney-in-Fact 2022-03-11